共 8 条
[1]
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy - Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (09)
:2793-2806
[2]
The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment - Results of a phase IIb randomized, double-blind, placebo-controlled, dose-ranging trial
[J].
ARTHRITIS AND RHEUMATISM,
2006, 54 (05)
:1390-1400
[6]
Téllez-Zenteno JF, 2003, NEUROLOGIA, V18, P54
[7]
ASSOCIATED DISORDERS IN MYASTHENIA-GRAVIS - AUTOIMMUNE-DISEASES AND THEIR RELATION TO THYMECTOMY
[J].
ACTA NEUROLOGICA SCANDINAVICA,
1989, 80 (04)
:290-295